Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
Clinical trial NCT03258593 · COMPLETED
Trial details
- NCT number
- NCT03258593
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2022-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.